Cointime

Mast Therapeutics

company

About

Mast Therapeutics is a biopharmaceutical company developing novel, clinical-stage therapies for serious or life-threatening diseases.

  • 11 - 50

Highlights

Total Funding Amount
$15M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Post-IPO Debt
Last Funding Money Raised
$15M
Industries
Biopharma,Biotechnology,Health Care
Founded date
Jan 1, 1995
Number Of Employee
11 - 50
Operating Status
Close

(NYSE MKT: MSTX) We are a San Diego-based biopharmaceutical company developing proprietary product candidates to treat various diseases and conditions.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$15M
Mast Therapeutics has raised a total of $15M in funding over 2 rounds. Their latest funding was raised on Mar 1, 2016 from a Post-IPO Debt round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 1, 2016 Post-IPO Debt $15M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Mast Therapeutics is funded by 1 investors. Hercules Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Hercules Capital — Post-IPO Debt
Cointime
เนื้อหา
บริษัท